Use of population modeling to define rational monitoring of amiodarone hepatic effects
PT Pollak, SL Shafer - Clinical Pharmacology & Therapeutics, 2004 - Wiley Online Library
Background Amiodarone causes hepatotoxicity in experimental models, but in humans, the
relationships between drug administration, serum concentrations, markers of liver function …
relationships between drug administration, serum concentrations, markers of liver function …
Prevalence of amiodarone‐related hepatotoxicity in 720 Chinese patients with or without baseline liver dysfunction
LCC Kum, WWL Chan, HHY Hui… - … Indexed and Peer …, 2006 - Wiley Online Library
Background: The prevalence of hepatotoxicity after longterm oral amiodarone therapy in
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …
Chinese patients with or without elevated liver enzymes at baseline is unknown. Hypothesis …
Technetium-99m hexamethylpropylene amine oxime lung scintigraphy findings in low-dose amiodarone therapy
Amiodarone (AD)-induced pulmonary toxicity is one of the major complications of long-term
AD therapy. Technetium-99m-labeled D, L-hexamethylpropylene amine oxime (Tc-99m …
AD therapy. Technetium-99m-labeled D, L-hexamethylpropylene amine oxime (Tc-99m …